Create a Report

Please provide report title
Please provide location
Please provide details

Add more

Get alerts and updates for your case!

This information is not shown on the website. We can notify you of updates, and may contact you for more information to help resolve or follow up on your issue.

Please provide email or phone
Please provide email or phone

We do not show your email or contact info

Skip this step

Add photos or video

We recommend photos and videos to help explain your report

Add Photo/Video
Drop files here
Skip this step

Email or SMS copy of report

Enter below to get emailed a copy of your report, or sms a link to your report

Please provide email or phone
Please provide email or phone

Thank you for your report!

The report was
successfully sent!


Your report is queued - it may take up to 12 hours to process your report.


Email us at support@safelyhq.com if you have questions.

Safety Report: GNC Women's 30+ Vitapak recalled due to Undeclared Fish Allergen, USA

1 week ago source accessdata.fda.gov

Recall notice

United States

GNC Holdings LLC has issued a recall for its Women's 30+ Vitapak due to an undeclared fish allergen, parvalbumin. The product was distributed across multiple states including AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, PR, RI, SC, TN, TX, UT, VA, WA, WI, WV, WY.

The recall was initiated on April 25, 2025, and was classified as Class III by the FDA on June 5, 2025.

The recall involves:
- Name: GNC Women’s 30+ Vitapak
- Packaging: Carton of 30 sachets; each sachet contains four tablets and one capsule
- Lot Numbers:
1060EB2401, 1060EB2402, 1060EB2403, 1060EB2404, 1060EB2405, 1060EB2501, 1060EB2502, 1060EB2503
- Package Dimensions: 10.25” W x 3.56” H x 3.15” D
- Quantity Recalled: 144,430 units

In case you experience harm from allergens or undeclared ingredients, it is important to report it. It can help to detect & resolve issues and prevent others from being harmed, and it enables better surveillance. If symptoms persist, seek medical care.

Source: www.accessdata.fda.gov/scripts/ires/index.cfm

#allergicreaction #supplement #recall #unitedstates #allergen

Recent Reports Near Me